LoginSignup
CBS

Cannabist Stock

StockStock
ISIN: CA13765Y1034
Ticker: CBST
CA13765Y1034
CBST

Price

Frequently asked questions

What is Cannabist's market capitalization?

The market capitalization of Cannabist is $54.70M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Cannabist?

Cannabist's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.298. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Cannabist's stock?

Currently, 8 analysts cover Cannabist's stock, with a consensus target price of $1.171. Analyst ratings provide insights into the stock's expected performance.

What is Cannabist's revenue over the trailing twelve months?

Over the trailing twelve months, Cannabist reported a revenue of $489.89M.

What is the EBITDA for Cannabist?

Cannabist's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $63.25M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Cannabist?

Cannabist has a free cash flow of -$24.09M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Cannabist's stock?

The 5-year beta for Cannabist is 1.61. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Cannabist have, and what sector and industry does it belong to?

Cannabist employs approximately 2,191 people. It operates in the Health Care sector, specifically within the Crops industry.

What is the free float of Cannabist's shares?

The free float of Cannabist is 419.70M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $54.70M

5Y beta

 1.61

EPS (TTM)

 -$0.298

Free Float

 419.70M

Revenue (TTM)

 $489.89M

EBITDA (TTM)

 $63.25M

Free Cashflow (TTM)

 -$24.09M

Pricing

1D span
$0.118$0.163
52W span
$0.193$0.278

Analyst Ratings

The price target is $1.171 and the stock is covered by 8 analysts.

Buy

6

Hold

2

Sell

0

Information

The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with operations in 13 United States jurisdictions. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates approximately 95 facilities, including 73 dispensaries and 22 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures brands, including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.

2,191

Crops

Health Care

Identifier

ISIN

CA13765Y1034

Primary Ticker

CBST

Knockouts

Join the conversation
Sign upLogin